NASDAQ: OLMA
Olema Pharmaceuticals Inc Stock Ownership - Who owns Olema Pharmaceuticals?

Insider buying vs selling

Have Olema Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bain Capital Life Sciences Investors LLC10% Owner2025-01-08300,000$5.76
$1.73MBuy
G. Walmsley GrahamDirector2024-12-17700,761$6.75
$4.73MSell
G. Walmsley GrahamDirector2024-12-17700,761$6.75
$4.73MBuy
Naseem ZojwallaCHIEF MEDICAL OFFICER2024-12-1614,000$4.87
$68.18kBuy
G. Walmsley GrahamDirector2024-12-13700,761$6.75
$4.73MSell
G. Walmsley GrahamDirector2024-12-13700,761$6.75
$4.73MBuy
David C. MylesCH. DISCOV. NON-CLIN DEV OFF2024-12-11300$9.39
$2.82kSell
David C. MylesCH. DISCOV. NON-CLIN DEV OFF2024-12-1113,314$8.66
$115.30kSell
Shane William Charles KovacsCH. OPERATING FINANCIAL OFF.2024-12-11406$9.39
$3.81kSell
Cyrus HarmonDirector2024-12-11179$9.39
$1.68kSell

1 of 5

OLMA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OLMA insiders and whales buy or sell their stock.

OLMA Shareholders

What type of owners hold Olema Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bain Capital Life Sciences Investors LLC13.09%7,500,000$37.28MInsider
Bain Capital Life Sciences Investors LLC13.04%7,470,214$37.13MInstitution
Paradigm Biocapital Advisors LP12.75%7,304,970$36.31MInstitution
Paradigm Biocapital Advisors LP9.61%5,503,600$27.35MInsider
Blackrock Inc6.61%3,789,832$18.84MInstitution
Deep Track Capital LP6.01%3,442,833$17.11MInstitution
Cormorant Asset Management LP5.71%3,270,544$16.25MInsider
Logos Global Management LP5.60%3,208,875$15.95MInstitution
Vanguard Group Inc4.69%2,685,009$13.34MInstitution
Pictet Asset Management Holding Sa3.29%1,883,354$9.36MInstitution

1 of 3

OLMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OLMA66.69%33.31%Net SellingNet Buying
IMMP0.13%0.00%
LXRX23.45%76.55%Net Buying
ALMS49.96%33.14%Net Buying
ATYR52.77%18.32%Net BuyingNet Selling

Olema Pharmaceuticals Stock Ownership FAQ

Who owns Olema Pharmaceuticals?

Olema Pharmaceuticals (NASDAQ: OLMA) is owned by 87.22% institutional shareholders, 43.57% Olema Pharmaceuticals insiders, and 0.00% retail investors. Bain Capital Life Sciences Investors LLC is the largest individual Olema Pharmaceuticals shareholder, owning 7.50M shares representing 13.09% of the company. Bain Capital Life Sciences Investors LLC's Olema Pharmaceuticals shares are currently valued at $37.28M.

If you're new to stock investing, here's how to buy Olema Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.